Dr. Jeremy Ross, M.D.
What this data tells you about Dr. Ross
Dr. Jeremy Ross is a student in an organized health care education/training program in Fort Worth, TX, with 13 years in practice. Based on federal Medicare data, Dr. Ross performed 42,821 Medicare services across 1,228 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ross received a total of $347,259 from 39 pharmaceutical and/or device companies across 473 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 21,000 | $0 | $5 |
| Filgrastim injection (Nivestym) for white blood cells | 13,080 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,290 | $1 | $52 |
| Dexamethasone injection (steroid) | 2,274 | $0 | $5 |
| Injection of additional new drug or substance into vein | 596 | $12 | $70 |
| Flow cytometry, additional marker | 575 | $18 | $125 |
| Administration of chemotherapy into vein, 1 hour or less | 345 | $102 | $412 |
| Office visit, established patient, complex (40-54 min) | 325 | $139 | $350 |
| Office visit, established patient (30-39 min) | 292 | $97 | $275 |
| Hospital follow-up visit, high complexity | 235 | $93 | $250 |
| Administration of additional new drug or substance into vein, 1 hour or less | 217 | $50 | $202 |
| Office visit, established patient (20-29 min) | 201 | $63 | $175 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 196 | $23 | $100 |
| Administration of chemotherapy into vein, each additional hour | 165 | $22 | $93 |
| Hospital follow-up visit, moderate complexity | 122 | $62 | $175 |
| Drug injection, under skin or into muscle | 116 | $11 | $60 |
| Injection, diphenhydramine hcl, up to 50 mg | 112 | $1 | $10 |
| Ct scan of chest with contrast | 93 | $49 | $401 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 89 | $48 | $160 |
| CT scan of abdomen and pelvis with contrast | 85 | $164 | $681 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 75 | $48 | $190 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 75 | $16 | $60 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 36 | $1,141 | $4,069 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 31 | $37 | $120 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 29 | $106 | $450 |
| New patient office visit, complex (60-74 min) | 28 | $172 | $500 |
| Flow cytometry technique for dna or cell analysis, first marker | 25 | $54 | $200 |
| Initial hospital admission, high complexity | 24 | $135 | $500 |
| New patient office visit (45-59 min) | 22 | $125 | $400 |
| Advance care planning consultation, first 30 min | 19 | $65 | $250 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $27 | $105 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 17 | $1 | $5 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $25 | $100 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for student in an organized health care education/training program in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ross is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 0%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ross experienced with anti-nausea injection (fosaprepitant)?
Does Dr. Ross receive payments from pharmaceutical companies?
How do Dr. Ross's costs compare to other student in an organized health care education/training programs in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology